Who are Gonal-F, Fostimon's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): rFSH drug dose, rhFSH+rhLH, Recombinant FSH (rFSH), Ovarian Stimulation with rFSH, ovarian stimulation, rFSH (Gonal®,.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/gonal-f-fostimon.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Gonal-F, Fostimon — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gonal-F, Fostimon (Gonal-F, Fostimon) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: FSH analog. Area: Oncology.

phase 2 FSH analog FSH receptor Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Gonal-F, Fostimon (Gonal-F, Fostimon) — Genesis Center for Fertility & Human Pre-Implantation Genetics. Stimulates the production of follicle-stimulating hormone (FSH)

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Gonal-F, Fostimon TARGET	Gonal-F, Fostimon	Genesis Center for Fertility & Human Pre-Implantation Genetics	phase 2	FSH analog	FSH receptor
rFSH drug dose	rFSH drug dose	Nina la Cour Freiesleben	marketed	Gonadotropin	FSH receptor (FSHR)
rhFSH+rhLH	rhFSH+rhLH	Fundación Santiago Dexeus Font	marketed	Gonadotropin	FSH receptor and LH receptor
Recombinant FSH (rFSH)	Recombinant FSH (rFSH)	AGUNCO Obstetrics and Gynecology Centre	marketed	Gonadotropin	FSH receptor (FSHR)
Ovarian Stimulation with rFSH	Ovarian Stimulation with rFSH	Fundación Santiago Dexeus Font	marketed	Gonadotropin	FSH receptor (FSHR)
ovarian stimulation	ovarian stimulation	Ain Shams Maternity Hospital	marketed	Gonadotropin	FSH receptor, LH receptor
rFSH (Gonal®,	rFSH (Gonal®,	Instituto Valenciano de Infertilidad, IVI VALENCIA	marketed	Gonadotropin	FSH receptor (FSHR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (FSH analog class)

Genesis Center for Fertility & Human Pre-Implantation Genetics · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Gonal-F, Fostimon — Competitive Intelligence Brief. https://druglandscape.com/ci/gonal-f-fostimon. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab